CrystalGenomics to merge with BexPharm Pharmaceuticals - MarketLine Financial Deals

CrystalGenomics to merge with BexPharm Pharmaceuticals

CrystalGenomics to merge with BexPharm Pharmaceuticals - MarketLine Financial Deals
CrystalGenomics to merge with BexPharm Pharmaceuticals
Published May 28, 2010
2 pages — Published May 28, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

CrystalGenomics, Inc. will merge with BexPharm, a specialty pharmaceutical company that primarily deals with inpatient prescription products.

  
Source:
Document ID
MA26014_100601
Country
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "CrystalGenomics to merge with BexPharm Pharmaceuticals" May 28, 2010. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CrystalGenomics-to-merge-with-BexPharm-Pharmaceuticals-2052-33955>
  
APA:
MarketLine Financial Deals. (2010). CrystalGenomics to merge with BexPharm Pharmaceuticals May 28, 2010. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CrystalGenomics-to-merge-with-BexPharm-Pharmaceuticals-2052-33955>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.